Overview

Adjuvant Growth Therapy in in Vitro Fertilization

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
In an In Vitro Fertilization (IVF) cycle super ovulating drugs (gonadotropins) are usually taken to stimulate the ovaries to produce more than one egg. In Vitro Fertilization protocols are constantly under review in order to improve the recruitment of the follicles, which contain the eggs, whilst minimizing the doses of gonadotrophins required, with the ultimate aim of increasing the live birth rate.
Phase:
Phase 4
Details
Lead Sponsor:
Clinique Ovo
OVO R & D
Collaborator:
EMD Serono